| N |
Investment project title |
Bacteriophages against multidrug resistant Salmonella |
| 1. |
Sector |
Biomedicine |
| 2. |
Project description |
To combat against multidrug resistant strains (MDR) of Salmonella in Armenia, isolation and investigation of bacteriophages (phages) have been performed.
In collaboration with the G. Eliava Institute of Bacteriophages, Microbiology and Virology bacteriophages were isolated which due to mode of action different from antibiotics, showed high efficiency against MDR strains of Salmonella.
Phage cocktails consisting of different phages displayed even more efficiency and soon will be able to replace a number of antimicrobials |
| 3. |
Project implementation period |
4 years |
| 4. |
Project location |
Institute of Molecular Biology of NAS RA |
| 5. |
Project overall cost (USD) |
500.000 |
| 6. |
Required investments (USD) |
300.000 |
| 7. |
Own funds (USD) |
200.000 (has been already invested in R&D and preliminary trials) |
| 8. |
Creation of jobs |
At the beginning of the project |
At the end of the project |
| 5-10 |
30-50 |
| 9. |
Payback period |
2-3 years |
| 10. |
Annual profitability index |
1.05-1.1 |
| 11. |
Detailed costs |
Equipment - 150.000
Implementation - 15.000
Materials - 85.000
Salary - 50.000 |
| 12. |
Offer to investor |
The organization of a joint venture, an investor’s share will depend on the amount of invested funds and project involvement stage |
| 13. |
Contact details |
Arsen Arakelyan, Director of the Institute of Molecular Biology of NAS RA
E-mail: aarakelyan {[ at ]} sci.am
Tel.: (+374 10) 281626 |
![academy [@] sci.am](images/email.jpg "academy [@] sci.am")
